Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biosimilar
Marketing
Coherus loses commercial chief amid exit from biosimilar space
As the biotech completes its pivot away from biosimilars, Reider has resigned as chief commercial officer to pursue other opportunities.
Nick Paul Taylor
Apr 23, 2025 11:19am
Health plan sues AZ's Alexion over 'fraudulent' Soliris patents
Apr 17, 2025 10:50am
Sanofi gains FDA nod for first biosimilar version of NovoLog
Feb 18, 2025 11:05am
IRA biosim policy plays 'small' role in savings so far: report
Aug 29, 2024 1:35pm
BI taps GoodRx to offer its Humira biosim at a steep markdown
Jul 18, 2024 11:15am
Italy opens antitrust case against Novartis, Biogen and others
Jun 6, 2024 11:39am
.jpg?VersionId=hNnA1s2kkPYoMW.DjWt.7XHVnURyXXf7)
